Compound E - Moligand™, 10 mM in DMSO , CAS No.209986-17-4

CAS: 209986-17-4 Cat. No.: C1496924 Formula: C27H24F2N4O3 Molecular Weight: 490.50
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10 mM in DMSO
Storage
Protected from light,Desiccated,Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Size
Germany (EU)
USA*
Price
Qty
1ml
C1496924-1ml
Made to order · 8–12 wks
€511.88
Enter a quantity for the sizes you want to add.

Overview

Compound E is a γ-secretase inhibitor. Compound E bloks β-amyloid(40), β-amyloid(42), and Notch γ-secretase cleavage with IC 50 s of 0.24, 0.37, 0.32 nM, respectively.

Specifications

Specifications & Purity
Moligand™, 10 mM in DMSO
Storage
Protected from light,Desiccated,Store at -80°C
Shipped In
Dry ice packs + Cold packs
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
INHIBITOR
Names and Identifiers
Isomeric SMILES
C[C@@H](C(=O)N[C@@H]1C(=O)N(C2=CC=CC=C2C(=N1)C3=CC=CC=C3)C)NC(=O)CC4=CC(=CC(=C4)F)F
Molecular Weight
490.50
Reaxys
24842893
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24842893&ln=

Advanced Data

Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Safety and Hazards(GHS)
Reaxys
24842893
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24842893&ln=
Solution Calculators
Reviews

Customer Reviews

Application Protocols

Item-specific validated applications

  • Not specified for this item; no in-house tested protocols are provided in the Product Data for this SKU.

General/literature-style workflow suggestions (for planning only)

  • Stock solution: Prepare 5–10 mM in dry DMSO, aliquot, protect from light, store at −80°C.
  • Cell-based assays: Titrate across a broad concentration range (e.g., 0.1 nM to 10 µM) with matched DMSO controls; confirm cell health and exposure.
  • Biochemical assays: Pre-incubate compound with enzyme/protein target per assay design (e.g., 10–30 min) before initiating reaction; monitor activity with appropriate readouts.
  • Stability checks: Analyze pre- and post-assay samples by LC–MS to confirm compound integrity and concentration.

Please validate conditions in your laboratory and consult the literature for target-specific parameters.

Biological Roles

General/literature context (non-clinical; for research use only)

  • Compound E is widely described in the academic literature as a potent small-molecule modulator/inhibitor of the γ-secretase complex, thereby impacting intramembrane proteolysis events such as Notch receptor processing in cell-based systems. These uses are strictly research-oriented and not therapeutic claims.

Research utility

  • Tool compound: Enables interrogation of γ-secretase-dependent signaling cascades, aiding pathway mapping and target validation in biochemical assays and cultured cells.
  • Benchmarking: Serves as a reference for comparing potency/selectivity profiles of novel γ-secretase modulators.

Caveats and controls

  • Off-targets and pathway crosstalk can occur; include orthogonal assays and genetic controls (e.g., siRNA/CRISPR) to confirm on-target effects.
  • Cellular uptake and efflux transporters may influence apparent potency; verify exposure by LC–MS where possible.

Item-specific biological data

  • None provided in the Product Data for this SKU. Users should consult primary literature linked to CAS 209986-17-4 and validate performance under their specific conditions.
Buffer Applications

Not typically applicable

  • Compound E is a bioactive small molecule, not a buffering agent. It does not serve as a pH buffer component in standard laboratory recipes.

Relevant guidance for assay buffers

  • When using in biochemical or cell-based assays, prepare concentrated DMSO stocks and dilute into the desired biological buffer immediately before use, maintaining consistent DMSO content across controls and treatments.
  • If precipitation occurs, consider modest increases in co-solvent (e.g., up to 0.2–0.5% DMSO) while monitoring assay compatibility.
Green Alternatives

Context

  • As a bioactive library member, Compound E is not a process solvent or commodity reagent where green substitution frameworks typically apply. Nevertheless, greener practice can be considered for handling and assay workflows.

Greener handling considerations (general)

  • Minimize DMSO volumes and prepare concentrated stocks to reduce solvent waste.
  • Use microscale assay formats (96/384/1536-well) to limit chemical usage and waste generation.
  • Prefer aqueous assay buffers with the lowest feasible DMSO content that maintains solubility and performance.

Comparison of common stock solvents (general)

  • DMSO: High solvating power; fully water-miscible; relatively low volatility; known to enhance skin permeation—handle carefully.
  • Ethanol: More benign profile but lower solvating power for many hydrophobic bioactives; evaporation can change concentration.
  • PEG400: Useful co-solvent for in vivo formulation studies (not applicable here); high viscosity complicates high-throughput use.

Note

  • No direct “green alternative” exists for the compound itself. Environmental footprint improvements are best achieved via solvent minimization, microscale experimentation, and appropriate waste segregation/recycling where permitted.
Pharmaceutical Uses

Scope

  • This product is supplied strictly for research use only. It is not intended for human or veterinary use, diagnostic use, or as an active pharmaceutical ingredient.

Research/formulation context (general)

  • In drug discovery workflows, Compound E is commonly employed as a reference tool in screening and mechanism-of-action studies. When formulated for in vitro assays, DMSO stock solutions are typical. Any excipient or vehicle selection should be guided by the assay system and compatibility with the biological model.

Standards and compliance

  • Pharmacopeial status: Not specified for this item; refer to CoA/Spec Sheet if applicable.
  • If used as an internal standard or control article in regulated studies, users should establish fit-for-purpose qualification, including identity, purity, and stability documentation.

Note

  • No clinical indications are claimed or implied. All usage must comply with institutional and regulatory guidelines for research chemicals.
Physical Properties

Item-specific physical properties

  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not applicable/unknown for this solid bioactive; Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa(s): Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable (solid) or not specified; refer to CoA/Spec Sheet.

General/literature guidance (non-binding; for planning only)

  • Many researchers handle Compound E as a hydrophobic solid and prepare concentrated stock solutions in anhydrous DMSO (e.g., 1–10 mM) for in vitro assays. Actual solubility limits depend on batch and solvent quality.
  • Compatibility: DMSO, DMF, and other polar aprotic solvents are commonly used for bioactives of similar class; aqueous buffers typically require co-solvent or surfactant to avoid precipitation.
  • Stability: Light- and moisture-sensitive handling is advisable; storage at ultra-low temperature helps maintain integrity over time (see Storage & Reconstitution tab for item-specific guidance).

Note: For experimental design and quantitative property needs, consult the SDS and the product’s CoA/Spec Sheet for definitive specifications.

Quality & Grades

Item-specific details

  • Grade/Purity: Moligand™ (Aladdin small-molecule/ligand library grade).

What Moligand™ implies (general guidance)

  • Curated for research screening, target engagement studies, and assay development. Emphasis is on identity confirmation and suitability for biochemical and cell-based assays, rather than application as a bulk synthetic reagent.
  • Typical control elements for such grades include structural verification (e.g., NMR/HRMS), and a documented purity metric appropriate for screening use. Exact analytical acceptance criteria, stabilizers, water/peroxide limits, and metal content are Not specified for this item; refer to CoA/Spec Sheet.

UV/LC suitability

  • HPLC/UPLC analysis conditions for purity assessment are provided on request or via CoA; low-UV background is not guaranteed unless explicitly stated for this SKU.

Stabilizers/additives

  • Not specified for this item; refer to CoA/Spec Sheet. If present, stabilizers can affect downstream biological assays; adjust controls accordingly.

Traceability and documentation

  • Each batch is traceable by lot number; request the CoA for exact purity, analytical methods, and any item-specific handling instructions.
Reaction & Applications

Scope for this product

  • This SKU is positioned as a Moligand™ research compound rather than a synthetic reagent. Its primary use is in biochemical or cell-based assay workflows, target validation studies, and small-molecule library screening.

Applications (research context; non-clinical)

  • Tool compound usage: Employed as a reference/positive control in signaling pathway investigations and enzyme modulation studies in vitro.
  • Assay development: Calibration of assay dynamic range, IC50 benchmarking across cell lines or enzyme preparations, and orthogonal validation using alternative readouts (e.g., reporter assays vs. biochemical activity).

Practical tips

  • Prepare fresh working dilutions immediately prior to use to minimize adsorptive loss and degradation.
  • Include solvent-only controls that match the DMSO percentage in treated wells/samples.
  • For time-course studies, confirm stability under assay conditions by analytical spot checks (e.g., LC–MS at start/end).

Not typical

  • This compound is not generally used as a reagent for named organic reactions, catalysts, or stoichiometric transformations. For chemical synthesis tasks, consider dedicated reagents in our catalog tailored to the target transformation.
Reaction Conditions

Applicability

  • This product is not intended for use as a reagent in chemical transformations; therefore, no item-specific reaction conditions are provided.

General guidance for assay preparation (not synthetic reactions)

  • Stock preparation: Dissolve the solid in anhydrous DMSO to a convenient concentration (e.g., 5–10 mM), protected from light. Vortex and, if needed, brief sonication to aid dissolution.
  • Working solutions: Dilute stocks into pre-warmed assay buffer to final DMSO ≤0.1–0.5% v/v, unless your assay tolerates higher.
  • Temperature: Prepare and handle on ice or at room temperature depending on assay needs; avoid prolonged exposure to elevated temperatures to limit degradation.
  • Filtration: 0.2 µm PTFE/RC filtration can remove particulates; verify no significant adsorptive loss.

Quality controls

  • Run solvent-only controls and, where relevant, a known reference compound to benchmark assay performance.

Note

  • For any chemical transformation involving this molecule (e.g., derivatization), develop conditions de novo and confirm stability; no standard reaction conditions are endorsed for this SKU.
Safety & Handling

Item-specific safety information

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word: Not specified for this item; refer to SDS.
  • Hazard statements (H-phrases): Not specified for this item; refer to SDS.
  • Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (best practice; defer to SDS for authority)

  • Handle in a chemical fume hood and avoid inhalation, ingestion, and skin/eye contact.
  • Use appropriate PPE: lab coat, safety glasses, and suitable chemically resistant gloves (e.g., nitrile). For solid handling, consider dust mask/respirator per risk assessment.
  • Avoid exposure to light and moisture per item storage instructions; minimize repeated freeze–thaw events.
  • Incompatibilities (general for hydrophobic bioactives): strong oxidizers, strong acids/bases may cause degradation; avoid prolonged exposure to aqueous media without proper co-solvent.

First-aid overview (general)

  • Skin/eye contact: Rinse with copious water for at least 15 minutes; remove contaminated clothing; seek medical evaluation.
  • Inhalation: Move to fresh air; monitor breathing; seek medical attention if symptoms persist.
  • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.

Waste disposal

  • Dispose of residues and contaminated materials as hazardous chemical waste in accordance with institutional and local regulations.

Always consult the official SDS for definitive hazard, exposure controls, and emergency measures.

Solvent Selection

Applicability

  • As a bioactive small molecule typically handled in micro-milligram to milligram quantities, solvent choice focuses on preparing stable stock solutions for screening assays rather than bulk synthesis.

General/literature guidance (not item-specific)

  • Primary stock solvent: Anhydrous DMSO is commonly used for Compound E and related hydrophobic modulators; typical stock concentrations 1–10 mM, protected from light.
  • Alternative solvents: DMF and NMP are viable for difficult solubilization; ethanol or isopropanol can sometimes aid co-solubilization but may be less compatible with certain assays.
  • Aqueous use: Dilute DMSO stocks into assay buffer immediately before use to achieve desired final concentration and ≤0.1–0.5% v/v DMSO (as assay-compatible), preventing precipitation.
  • Filtration: If particulate matter is observed, pass through a low-protein-binding 0.2 µm PTFE/RC filter. Avoid cellulose acetate for DMSO stocks.

Polarity/miscibility context (general)

  • DMSO is fully miscible with water, enabling convenient serial dilutions while limiting compound precipitation.

Item-specific solubility and UV cutoff

  • Not specified for this item; refer to CoA/Spec Sheet for any reported solubility or spectroscopic parameters.
Storage & Reconstitution

Item-specific storage conditions (from Product Data)

  • Storage: Store at −80°C, protected from light, desiccated.
  • Shipping: Shipped on dry ice packs + cold packs to maintain low temperature.

Reconstitution guidance (general; adapt to your assay)

  • Solvent: Use anhydrous DMSO for initial dissolution unless your CoA specifies otherwise.
  • Concentration: Prepare concentrated stocks (e.g., 5–10 mM) to minimize freeze–thaw and solvent usage.
  • Aliquoting: Dispense into single-use, light-protective microtubes under dry inert atmosphere if possible to limit moisture/oxygen exposure.
  • Freeze–thaw: Avoid repeated cycles; thaw on ice, mix gently, and promptly refreeze unused portions.

Stability notes

  • Keep protected from ambient light during handling and storage. Moisture ingress may lower potency or cause degradation.
  • For long-term projects, periodically re-check potency/purity by LC–MS or HPLC.

Unspecified parameters

  • Appearance, stabilizers, and exact solubility: Not specified for this item; refer to CoA/Spec Sheet.

Research use only. Use in compliance with institutional safety procedures and consult the SDS for definitive handling guidance.

Structure & Identity

Brief overview: This listing is for “Compound E” (often cited in research use as a bioactive small molecule), supplied as a Moligand™-grade library member.

Item-specific facts (from Product Data)

  • CAS: 209986-17-4
  • PubChem CID: 11306390
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

General/literature context (informational; not item specifications)

  • “Compound E” is a widely referenced research compound in chemical biology literature, commonly discussed as a potent modulator of γ-secretase activity (non-clinical, in vitro use).
  • Structural features reported in literature typically describe a non-volatile, hydrophobic small molecule with multiple aromatic/aryl-like fragments and amide-like functionality; exact stereochemistry and substituent pattern should be verified against the CAS-linked structure.

2D structural description (general)

  • Literature depictions show an organic small molecule with aromatic rings and polar functional groups embedded in an otherwise hydrophobic scaffold, consistent with cell-permeable bioactives. Precise 2D atom connectivity, stereocenters, and protonation state should be confirmed from the certificate of analysis (CoA) for this SKU.
Synthetic Utility

Not a general synthetic building block

  • Compound E is sold as a bioactive tool compound rather than as a precursor for multistep organic synthesis. It is not commonly employed in named reactions or as a coupling partner.

If adapting for synthetic studies (general considerations)

  • Functional group compatibility: Literature depictions suggest multiple heteroatom-containing moieties; exposure to strong acids/bases, oxidants, or high temperatures may lead to degradation.
  • Protection/derivatization: If analog generation is desired, plan strategies around the most labile functional groups (e.g., amide/urea/aryl-ether motifs as applicable to the confirmed structure from the CAS record).

Analytical characterization

  • Confirm identity and purity by orthogonal methods (e.g., 1H/13C NMR, LC–MS, HRMS). For impurity profiling and degradation pathways, stress-testing under assay-relevant conditions (light, moisture, temperature) is recommended.

Bottom line

  • For synthetic methodology development, consider dedicated reagents and building blocks. Use this compound as a reference standard or tool where its bioactivity is the primary value.
Target Specificity

Item-specific target data

  • Not specified for this item; refer to CoA/Spec Sheet or the primary literature associated with CAS 209986-17-4.

General note

  • While “Compound E” is often discussed in literature in the context of γ-secretase modulation, Aladdin does not assert target specificity for this SKU beyond what is documented in product-level data. Users should verify target engagement in their own system with appropriate controls and orthogonal assays.

Frequently Asked Questions

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?80 °C, protected from light, desiccated. Keep the container tightly closed with desiccant — the material is moisture-sensitive.
How is this product shipped?
This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 209986-17-4, the molecular formula is C27H24F2N4O3, and the molecular weight is 490.50 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.